IRS2 and type 2 diabetes mellitus: In vivo experiments have demonstrated that mice deficient in insulin receptor substrate 2 (IRS-2) develop T2DM, in part due to a significant reduction in β-cell mass [16], [17], and that the targeted re-expression of IRS-2 in β-cells enhances their survival and promotes growth, mainly via increased proliferation [18].